SPAG9 and nonpapillary renal cell carcinoma: This study combined a bioinformatics analysis and experimental validation, exploring the prognostic value of SPAG9 expression in ccRCC patients and the possible underlying mechanisms, and constructed a SPAG9-based ccRCC prognostic model to help with risk stratification.